Adimab Platform Patents. Adimab shall at all times remain the sole and exclusive owner of the Adimab Platform Patents.
Appears in 5 contracts
Sources: Assignment and License Agreement (Adagio Therapeutics, Inc.), Option and License Agreement, Option and License Agreement (Arsanis, Inc.)